AZMIRO is an androgen indicated for testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone:
Limitations of Use: • Safety and efficacy of AZMIRO in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established. • Safety and effectiveness in pediatric patients below the age of 12 years have not been established.
Source: the FDA label for Azmiro (Azurity Pharmaceuticals, Inc.), July 25, 2025. Full label on DailyMed
Good to know
A regular generic may look different from Azmiro. The FDA requires it to work the same way.
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked September 28, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/azmiro/